Maintaining Implementation Through Dynamic Adaptations (MIDAS) Suicide Prevention 2.0 Clinical Telehealth
MIDAS SPCT
1 other identifier
interventional
4
1 country
1
Brief Summary
Scientific advances are constantly leading to better treatments. However, it is quite challenging for healthcare systems, including VA, to ask very busy providers to change the way they practice. The MIDAS QUERI program helps providers improve the way they treat VA patients. This project will focus on increasing referrals to the Suicide Prevention 2.0 Clinical Telehealth (SP 2.0) initiative through the delivery of Academic Detailing and LEAP (a team-based quality improvement program). SP 2.0 provides accessible, evidence-based suicide prevention treatment to all Veterans with a history of suicidal self-directed violence or preparatory behaviors in the past 12 months.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Nov 2022
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
November 1, 2022
CompletedFirst Submitted
Initial submission to the registry
August 16, 2023
CompletedFirst Posted
Study publicly available on registry
August 25, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 29, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
August 29, 2024
CompletedResults Posted
Study results publicly available
December 29, 2025
CompletedDecember 29, 2025
December 1, 2025
1.8 years
August 16, 2023
August 27, 2025
December 8, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
SP2Clin Metric
The quarterly SP2Clin metric data is reported and available on a VA national dashboard. The SP2Clin metric is calculated by the number of suicide prevention telehealth consults submitted among those with a suicide behavior event.
Baseline to 12-months post-baseline
Secondary Outcomes (1)
Change in Number of Consults to SP 2.0 Clinic
Baseline to 12-months post-baseline
Other Outcomes (3)
Change in Quality Improvement Skills Application
Baseline to 12-months post-baseline
Provider Satisfaction With Academic Detailing
Post-first Academic Detailing session
Change in Provider Satisfaction With LEAP
Baseline to 12-months post-baseline
Study Arms (1)
Intervention
EXPERIMENTALA multi-faceted implementation intervention including qualitative interviews and feedback and optional delivery of Academic Detailing and/or LEAP.
Interventions
The National Resource Center for Academic Detailing (NaRCAD) describes AD as "an innovative, one-on-one outreach education technique that helps clinicians provide evidence-based care to their patients. Using an accurate, up-to-date synthesis of the best clinical evidence in an engaging format, academic detailers ignite clinician behavior change, ultimately improving patient health. A successful AD visit is highly interactive, always a dialogue, and assesses a clinician's individual needs, beliefs, attitudes, issues, and concerns in order to promote better \[practice\]."
Learn. Engage. Act. Process (LEAP) program is a structured 6-month core curriculum plus 6 monthly collaborative sessions. The LEAP quality improvement program engages frontline teams in sustained incremental improvements of EBPs over a six-month period, allowing space for busy clinicians to learn and immediately apply fundamental QI skills. LEAP encompasses: 1) a structured, accessible curriculum based on the Institute for Healthcare Improvement's (IHI) Model for Improvement and Plan-Do-Study-Act cycles of change; 2) team-based, hands-on learning, and 3) coaching support and a QI network to enhance learning and accountability.
Eligibility Criteria
You may qualify if:
- Note- the investigators are recruiting clinics/medical centers - not individual patients. Prior to implementation, the investigators will work with sites to ensure they have met the preconditions necessary to begin sustained optimization of the EBP:
- \) a team leader or champion
- \) an identified department with service leadership buy-in and control over the processes/practices impacted by the implementation
- \) readily accessible data to measure process and impact of the implementation and use of the EBP
- \) availability of required resources
You may not qualify if:
- N/A
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
VA Ann Arbor Healthcare System, Ann Arbor, MI
Ann Arbor, Michigan, 48105-2303, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Limitations and Caveats
Site-level engagement in the intervention components was limited across sites.
Results Point of Contact
- Title
- Paul Pfeiffer, MD, MS, Corresponding Principal Investigator
- Organization
- VA Ann Arbor Health Care System
Study Officials
- PRINCIPAL INVESTIGATOR
Paul N Pfeiffer, MD MS
VA Ann Arbor Healthcare System, Ann Arbor, MI
- PRINCIPAL INVESTIGATOR
Jacob E Kurlander, MD MS MS
VA Ann Arbor Healthcare System, Ann Arbor, MI
- PRINCIPAL INVESTIGATOR
Jeremy B. Sussman, MD MS
VA Ann Arbor Healthcare System, Ann Arbor, MI
Publication Agreements
- PI is Sponsor Employee
- Yes
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- HEALTH SERVICES RESEARCH
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- FED
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
August 16, 2023
First Posted
August 25, 2023
Study Start
November 1, 2022
Primary Completion
August 29, 2024
Study Completion
August 29, 2024
Last Updated
December 29, 2025
Results First Posted
December 29, 2025
Record last verified: 2025-12
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL, ANALYTIC CODE
- Time Frame
- For 36 months after article is published.
- Access Criteria
- Upon request by researchers who provide a methodologically sound proposal. Further details will be available.
Site-level data that underlie results reported, after de-identification will be available.